Clinical trial
High Dose Daunorubicin Vs. Standard Dose Daunorubicin in Induction Treatment of…
NCT00474006 · Cooperative Study Group A for Hematology, Other · Completed
Key facts
| NCT number | NCT00474006 |
|---|---|
| Title | High Dose Daunorubicin Vs. Standard Dose Daunorubicin in Induction Treatment of AML |
| Official title | A RANDOMIZED COMPARISON OF TWO DIFFERENT DOSAGES OF DAUNORUBICIN IN INDUCTION TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA |
| Acronym | ADcomparison |
| Lead sponsor | Cooperative Study Group A for Hematology, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | ACUTE MYELOGENOUS LEUKEMIA |
| Intervention type | Drug |
| Interventions | arm II |
| Enrollment | 398 |
| Start date | Aug 1, 2001 |
| Primary completion | Aug 1, 2008 |
| Completion | Apr 1, 2010 |
| First posted | May 16, 2007 |
| Last update posted | Jun 10, 2011 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: